Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

Ozempic and similar weight loss drugs are currently at the center of multidistrict litigation over claims that the drugs ...

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes, and ...

The first step of setting up a new device starts with cleaning up your old phone. If you’re planning on trading in your old ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...

Yale Hospitality implemented a new Breakfast Express option, which includes a specialty coffee machine. Calories, sugar and ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Non-surgical weight loss treatments are becoming more accessible, effective, and more in tune with your body's natural ...

A new study forecasts more than 850,000 measles cases over the next 25 years if US vaccination rates stay the same. Millions ...